MRFF – SCTM – 2025 Stem Cell Therapies Grant Opportunity
The MRFF – SCTM – 2025 Stem Cell Therapies Grant Opportunity supports early-stage clinical trials of novel stem cell therapies (Phase I/IIa) and targeted research into ethical, regulatory, economic, and community aspects of stem cell medicine, to accelerate safe and effective treatments for Australians.
Key Information:
-
Agency: National Health and Medical Research Council (NHMRC)
-
Co-sponsored with: Department of Health and Aged Care
-
Grant ID: GO7561
-
Close Date & Time: 20 Aug 2025, 5:00 pm (ACT Local Time)
-
Selection Process: Targeted or Restricted Competitive
-
Total Funding Available: AUD 31,500,000
-
Estimated Grant Value: Up to AUD 5,000,000 per project
-
Location: All Australian States & Territories
Eligibility:
-
Applicants: Approved MRFF-Eligible Organisations (see NHMRC List of MRFF Eligible Organisations)
-
Requirements: Must comply with all criteria in the MRFF – SCTM – 2025 Stem Cell Therapies Grant Opportunity Guidelines.
Timeframes:
-
Minimum Data Submission: 23 Jul 2025, 5:00 pm (ACT)
-
Applications Close: 20 Aug 2025, 5:00 pm (ACT)
-
Questions Deadline: 13 Aug 2025, 1:00 pm (ACT)
How to Apply:
- Review the full Grant Guidelines on NHMRC’s website.
- Liaise with your approved MRFF-Eligible Organisation to confirm internal requirements.
- Submit electronically via NHMRC’s Sapphire system by the closing date.
Contact:
- Email: [email protected]
- Web.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023